Liven Pharma Limited (PSX:LIVEN)

Liven Pharma Ratios and Metrics

Market cap in millions PKR. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 11, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	3,930	6,042	110	185	152	303
Market Cap Growth	210.05%	5370.54%	-40.46%	21.91%	-49.80%	127.48%
Enterprise Value	3,959	6,080	349	423	387	535
Last Close Price	34.77	55.17	7.74	13.00	10.66	21.24
PE Ratio	-	-	2.65	-	-	-
PS Ratio	46.45	47.47	0.45	-	-	-
PB Ratio	6.22	9.53	0.15	-1.51	-1.38	-3.16
P/TBV Ratio	6.29	9.66	0.15	-	-	-
P/FCF Ratio	-	-	8.00	-	-	-
P/OCF Ratio	309.71	-	8.00	-	-	-
EV/Sales Ratio	46.78	47.77	1.42	-	-	-
EV/EBITDA Ratio	-	-	5.37	-	-	-
EV/EBIT Ratio	-	-	8.35	-	-	-
EV/FCF Ratio	-158.44	-	25.26	-	-	-
Debt / Equity Ratio	0.05	0.06	0.21	-1.94	-2.13	-2.43
Debt / EBITDA Ratio	-	-	2.35	-	-	-
Debt / FCF Ratio	-	-	11.37	-	-	-
Net Debt / Equity Ratio	0.05	0.04	0.18	-1.94	-2.13	-2.43
Net Debt / EBITDA Ratio	-0.06	-0.06	2.03	-111.87	-79.65	-110.82
Net Debt / FCF Ratio	-1.13	-1.09	9.56	-104.83	-104.11	-34.31
Asset Turnover	0.10	0.14	0.46	-	-	-
Inventory Turnover	0.65	0.90	-	-	-	-
Quick Ratio	0.10	0.19	0.71	0	0	0
Current Ratio	1.34	1.64	1.48	0	0	0.00
Return on Equity (ROE)	-91.87%	-84.49%	13.31%	-	-	-
Return on Assets (ROA)	-37.42%	-35.12%	4.93%	-6.89%	-7.20%	-6.80%
Return on Capital Employed (ROCE)	-75.50%	-67.10%	5.60%	14.20%	19.10%	24.50%
Earnings Yield	-17.95%	-9.67%	37.80%	-6.65%	-9.39%	-4.83%
FCF Yield	-0.64%	-0.41%	12.50%	-1.22%	-1.49%	-2.24%
Buyback Yield / Dilution	-417.79%	-174375.69%	99.67%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.